Zobrazeno 1 - 10
of 107
pro vyhledávání: '"Bernhard Saller"'
Autor:
Ann-Charlotte Åkerblad, Anders F Mattsson, Jose Cara, Rolf-Christian Gaillard, Bengt-Åke Bengtsson, Maria Koltowska-Häggström, Bernhard Saller, Patrick Wilton, Ulla Feldt-Rasmussen, John P. Monson, Roger Abs
Publikováno v:
European Journal of Endocrinology. 166:1069-1077
ObjectiveHypopituitarism is associated with an increased mortality rate but the reasons underlying this have not been fully elucidated. The purpose of this study was to evaluate mortality and associated factors within a large GH-replaced population o
Autor:
Dominique Maiter, Georg Brabant, Michael Buchfelder, Maria Koltowska-Häggström, Bernhard Saller, Andrew A. Toogood, Beverly M. K. Biller, Ulla Feldt-Rasmussen, Åse Krogh Rasmussen, Björn Jonsson
Publikováno v:
Endocrine Practice. 18:325-334
OBJECTIVE: To determine whether insulin tolerance tests (ITTs), arginine stimulation tests (ASTs), and glucagon stimulation tests (GST) identify patients who have similar clinical features of growth hormone (GH) deficiency when a diagnostic GH thresh
Autor:
Michael Buchfelder, Ulrich Tuschy, Harald Jörn Schneider, Henri Wallaschofski, Günter K. Stalla, Martina Jordan, Bernhard Saller, Steffen Fleck, Michael Faust, Caroline I.E. Renner, Anna Kopczak, M. Schneider, Ilonka Kreitschmann-Andermahr
Publikováno v:
Journal of Neurotrauma. 28:1693-1698
Clinical studies have demonstrated that traumatic brain injury (TBI) and aneurysmal subarachnoid hemorrhage (SAH) are frequent causes of long-term disturbances of hypothalamo-pituitary function. This study aimed to assess the prevalence and associate
Autor:
Harald Lahner, C. Berg, Michael Buchfelder, Susanne Moebus, Michael Droste, Karl-Heinz Jöckel, Christian J. Strasburger, Stephan Petersenn, B. L. Herrmann, Klaus Mann, Raimund Erbel, Ulla Roggenbuck, Bernhard Saller, Nils Lehmann, S Möhlenkamp, Günter K. Stalla
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 95:3648-3656
Data on cardiovascular risk in acromegaly are scanty and lack a clear correlation to epidemiological data.Our aim was an evaluation of cardiovascular risk factors in patients with active acromegaly, a calculation of the Framingham risk score (FRS) co
Autor:
A Reineke, E Yagmur, E. Poll, Bernhard Saller, JM Gilsbach, Ilonka Kreitschmann-Andermahr, Y Langejürgen
Publikováno v:
Experimental and Clinical Endocrinology & Diabetes. 116:276-281
Recent studies indicate that neuroendocrine dysfunction is a more frequent sequel of aneurysmal subarachnoid hemorrhage (SAH), than has so far been recognized. However, from the available data it remains unclear whether certain subgroups of SAH patie
Autor:
Michael Buchfelder, Peter Herbert Kann, Christian Wüster, Ulrich Tuschy, Bernhard Saller, Georg Brabant, Andrea Kleindienst, Panagiotis Nomikos
Publikováno v:
European Journal of Endocrinology. 157:149-156
Objective: Several studies documented metabolic and psychological benefits of GH substitution in deficient adults, most of them suffering from benign pituitary adenomas. Since GH substitution is considered to promote tumour regrowth, adequate treatme
Autor:
A Reineke, Joachim M. Gilsbach, Bernd O. Hutter, Sabine Kristes, Bernhard Saller, Eva Maria Poll, Ilonka Kreitschmann-Andermahr
Publikováno v:
Clinical Endocrinology. 66:833-837
Summary Objective Patients who have sustained aneurysmal subarachnoid haemorrhage (SAH) often suffer persistent impairments in their quality of life (QoL) and psychological disturbances despite a good neurological outcome. In the light of the high pr
Autor:
M Pirlich, J. Bauditz, Christian J. Strasburger, H. Biering, Michael Droste, Klaus Mann, Michael Buchfelder, I. Schreiber, A Johne, B Rudolph, H Lochs, Bernhard Saller
Publikováno v:
European Journal of Endocrinology. 154:213-220
Objective: The new GH receptor antagonist pegvisomant is the most effective medical therapy to normalize IGF-I levels in patients with acromegaly. Based on currently available data pegvisomant is well tolerated; however, treatment-induced elevation o
Publikováno v:
Hormone and Metabolic Research. 36:54-61
Abdominal obesity and insulin resistance are central findings in metabolic syndrome. Since treatment with recombinant human growth hormone (rhGH) can reduce body fat mass in patients with organic GH deficiency, rhGH therapy may also have favourable e
Der praktisch tätige Kliniker benötigt für die tägliche Arbeit Leitfäden, die rasch, übersichtlich und zuverlässig die relevanten Informationen zur Verfügung stellen. Die bisher verfügbare Literatur in der Endokrinologie kann dieser Anforder